FDA Inspection 1256490 — Actavis LLC

Actavis LLC — FEI 3009017204

The FDA completed an inspection of Actavis LLC on November 22, 2024 in Edison, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 22, 2024
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Edison, NJ (United States)